Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.59 USD | +0.82% | +4.78% | +0.97% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 32 | 100.0 % | 39 | 100.0 % | +23.60% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 32 | 100.0 % | 39 | 100.0 % | +23.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dan Omstead
PSD | President | 71 | 01/01/01 |
Jason Akus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Laura Woodward
CMP | Compliance Officer | 56 | 01/09/01 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 01/07/01 | |
Dan Omstead
PSD | President | 71 | 01/01/01 |
Jeffrey Bailey
BRD | Director/Board Member | 62 | 01/20/01 |
Director/Board Member | 73 | 17/22/17 | |
Thomas Kent
BRD | Director/Board Member | 71 | 19/17/19 |
Kathleen Goetz
BRD | Director/Board Member | - | 01/21/01 |
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,350,517 | 27,348,517 ( 99.99 %) | 0 | 99.99 % |
Company contact information
abrdn Life Sciences Investors
100 Federal Street 19th floor
02110, Boston
+215 405 5700
http://www.teklacap.com/hql.html1st Jan change | Capi. | |
---|---|---|
+0.97% | 372M | |
+2.90% | 12.53B | |
+10.40% | 5.66B | |
-3.76% | 5.38B | |
+7.80% | 5.3B | |
+10.77% | 4.35B | |
+14.15% | 4.35B | |
+1.77% | 4.07B | |
+5.13% | 3.91B | |
-2.36% | 3.21B |
- Stock Market
- Equities
- HQL Stock
- Company Abrdn Life Sciences Investors